首页 500强 活动 榜单 商业 科技 领导力 专题 品牌中心
杂志订阅

世界卫生组织警告:不要低估奥密克戎毒株的危险性

Jeremy Kahn
2022-01-05

世界卫生组织称,全球在该毒株对最易感人群的影响方面依然没有足够的数据。

文本设置
小号
默认
大号
Plus(0条)

尽管有初步研究表明,奥密克戎变种毒株的重症率要低于此前的新冠病毒毒株,但世界卫生组织(World Health Organization)就此发出警告,称全球在该毒株对最易感人群的影响方面依然没有足够的数据。

以下是世界卫生组织发出警告的原因:

南非:年龄和抗体

世界卫生组织的新冠事件负责人阿卜迪·马哈茂德博士称,尽管南非有关奥密克戎感染病症较轻的数据令人十分欣慰,但南非人口的年龄结构更加年轻。马哈茂德于2021年12月29日在日内瓦召开的新闻发布会上谈论奥密克戎毒株时说:“我们并不清楚它对年长以及易感人群会有什么样的影响。”

他表示,人们不应该“过度”解读南非的数据,并且称全球依然还需进一步了解奥密克戎毒株对未接种人群以及60岁以上人群的影响,也就是那些患有基础疾病、免疫系统遭到削弱的人群。

世界卫生组织卫生突发事件项目的执行主任迈克·瑞安还在同一个新闻发布会上指出,除了南非人口整体年龄比其他国家更加年轻之外,很大一部分南非人还拥有此前新冠病毒感染所产生的抗体。受此影响,我们可能很难判断奥密克戎毒株的重症率是否本来就低于以往新冠疫情的病毒毒株SARS-CoV-2。

欧洲:高接种率

瑞安称,从欧洲获得的数据在当前阶段亦难以得出确切的结论。很多欧洲国家的接种率很高,因此说到住院病患数量并未与感染率同步飙升的原因,我们很难确认到底是疫苗接种带来的重症防范效果,还是奥密克戎毒株本身重症率较低。

此外,欧洲的大多数奥密克戎感染病患到目前为止都是较为年轻的成年人。他说,病毒还未大幅侵袭60岁以上人群,因此,我们很难知道奥密克戎毒株对这个年龄段的人群到底有多危险。

瑞安说:“我们看到,奥密克戎毒株还未完全入侵各个年龄段的人群。在了解疫苗对年长和易感人群的保护效果之前,我不大愿意做出乐观的预测。”

瑞安还指出,众所周知,德尔塔变种毒株比其他早期毒株更容易引发重症,而且该毒株依然在欧洲地区传播,这一事实让欧洲的住院数据变得更加难以解读。

美国观点

有鉴于南非的数据,一些国家的卫生机构更倾向于认为奥密克戎毒株的危险性看起来要低于此前的毒株。在美国,白宫首席医疗顾问安东尼·福奇在2021年12月29日称,到目前为止,南非所有迹象表明,奥密克戎毒株的重症率要小于德尔塔毒株。然而他也明确表示,我们不能因此而盲目乐观,这一点很重要,因为美国人口结构与南非不同,而且我们并不清楚奥密克戎毒株到底会造成什么样的影响。(财富中文网)

译者:冯丰

审校:夏林

尽管有初步研究表明,奥密克戎变种毒株的重症率要低于此前的新冠病毒毒株,但世界卫生组织(World Health Organization)就此发出警告,称全球在该毒株对最易感人群的影响方面依然没有足够的数据。

以下是世界卫生组织发出警告的原因:

南非:年龄和抗体

世界卫生组织的新冠事件负责人阿卜迪·马哈茂德博士称,尽管南非有关奥密克戎感染病症较轻的数据令人十分欣慰,但南非人口的年龄结构更加年轻。马哈茂德于2021年12月29日在日内瓦召开的新闻发布会上谈论奥密克戎毒株时说:“我们并不清楚它对年长以及易感人群会有什么样的影响。”

他表示,人们不应该“过度”解读南非的数据,并且称全球依然还需进一步了解奥密克戎毒株对未接种人群以及60岁以上人群的影响,也就是那些患有基础疾病、免疫系统遭到削弱的人群。

世界卫生组织卫生突发事件项目的执行主任迈克·瑞安还在同一个新闻发布会上指出,除了南非人口整体年龄比其他国家更加年轻之外,很大一部分南非人还拥有此前新冠病毒感染所产生的抗体。受此影响,我们可能很难判断奥密克戎毒株的重症率是否本来就低于以往新冠疫情的病毒毒株SARS-CoV-2。

欧洲:高接种率

瑞安称,从欧洲获得的数据在当前阶段亦难以得出确切的结论。很多欧洲国家的接种率很高,因此说到住院病患数量并未与感染率同步飙升的原因,我们很难确认到底是疫苗接种带来的重症防范效果,还是奥密克戎毒株本身重症率较低。

此外,欧洲的大多数奥密克戎感染病患到目前为止都是较为年轻的成年人。他说,病毒还未大幅侵袭60岁以上人群,因此,我们很难知道奥密克戎毒株对这个年龄段的人群到底有多危险。

瑞安说:“我们看到,奥密克戎毒株还未完全入侵各个年龄段的人群。在了解疫苗对年长和易感人群的保护效果之前,我不大愿意做出乐观的预测。”

瑞安还指出,众所周知,德尔塔变种毒株比其他早期毒株更容易引发重症,而且该毒株依然在欧洲地区传播,这一事实让欧洲的住院数据变得更加难以解读。

美国观点

有鉴于南非的数据,一些国家的卫生机构更倾向于认为奥密克戎毒株的危险性看起来要低于此前的毒株。在美国,白宫首席医疗顾问安东尼·福奇在2021年12月29日称,到目前为止,南非所有迹象表明,奥密克戎毒株的重症率要小于德尔塔毒株。然而他也明确表示,我们不能因此而盲目乐观,这一点很重要,因为美国人口结构与南非不同,而且我们并不清楚奥密克戎毒株到底会造成什么样的影响。(财富中文网)

译者:冯丰

审校:夏林

The World Health Organization has sounded a note of caution over initial research that the Omicron variant is less likely to cause severe disease than previous coronavirus strains, saying that we still don't have enough data on how this version of the virus affects those who are most vulnerable.

Here's why the WHO is urging caution:

South Africa: Age and antibodies

Dr. Abdi Mahamud, the WHO’s incident manager for COVID-19, said that while data from South Africa suggesting Omicron causes milder illness was encouraging, the population in South Africa is mostly younger. "How it behaves in the elderly population, the vulnerable—we don’t know yet,” Mahamud said of Omicron during a press briefing in Geneva on December 29, 2021.

He said people should not "overinterpret" the South African data, saying the world still needed more information on how Omicron affects people over 60 years old, those with underlying medical conditions that weaken their immune response, and the unvaccinated.

Mike Ryan, executive director of the WHO health emergencies program, also said in the same press briefing that not only was the South African population generally younger than in other places, but that a large number of South Africans had also carried antibodies from prior COVID-19 infections. That might confound attempts to determine whether the Omicron strain is innately less likely to cause severe disease than prior variants of SARS-CoV-2, the virus that causes COVID-19.

Europe: High vaccination

Ryan said the data emerging out of Europe was also difficult to interpret at this stage. Many European countries have very high vaccination rates, which also makes it hard to tease out whether the fact hospitalizations have not soared in step with skyrocketing infection rates is largely due to protection against severe illness conferred by the vaccines or because Omicron is inherently less potent.

What's more, the majority of those infected with Omicron in Europe so far have been younger adults. The virus has yet to make major inroads into the over-60-year-old population, so it remains difficult to know how dangerous Omicron is to those in this age group, he said.

“What we haven’t seen is the Omicron wave fully established in the broader population,” Ryan said. “I’m a little nervous to make positive predictions until we see how well the vaccine protection is going to work in those older and more vulnerable populations.”

Also confounding the hospitalization data from Europe, Ryan said, is the fact that the Delta variant, which is known to be more likely to cause serious illness than some earlier strains of the virus, is still spreading there.

U. S. View

Some national health authorities have been more willing to say Omicron appears less dangerous than previous strains, based on the South African data. In the U.S., Anthony Fauci, the White House chief medical adviser, said on December 29, 2021 that so far all indications from South Africa suggested that Omicron causes less severe disease than the Delta variant. But he did say it was important not to become complacent, saying that U.S. demographics differed from South Africa's and it was unclear exactly what impact Omicron would have.

财富中文网所刊载内容之知识产权为财富媒体知识产权有限公司及/或相关权利人专属所有或持有。未经许可,禁止进行转载、摘编、复制及建立镜像等任何使用。
0条Plus
精彩评论
评论

撰写或查看更多评论

请打开财富Plus APP

前往打开